Fibrosis: Inflammation, Drivers, and Therapeutic Resolution

Dec 08–11, 2024 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers: Valerie Horsley, Michael T. Longaker and Thomas A Wynn

  In Person
  On Demand

Dec 08–11, 2024 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers: Valerie Horsley, Michael T. Longaker and Thomas A Wynn

Important Deadlines
Early Registration Deadline: Oct. 22, 2024
Scholarship Deadline: Sep. 10, 2024
Short Talk Abstract Deadline: Sep. 10, 2024
Poster Abstract Deadline: Nov. 14, 2024
Meeting Summary

# Immunology

This long-standing symposium will serve as an engaging platform for world-renowned researchers across the globe, both early-career and established, to exchange ideas, showcase pioneering findings, and foster fruitful collaborations on topics of clinical innovations, immunobiology, and mechnobiology in the field of fibrosis research. Workshops on multiomics and lessons across tissues combined with poster sessions, and in-depth discussions, will provide unparalleled opportunities for mentoring, training, and interactive scientific exchanges. With its wide-ranging scope of topics and unique opportunities for cross-industry and -disciplinary collaborations spanning different organ systems, no other event rivals the comprehensive platform offered by this program.

Meeting co-organizer, Dr. Valerie Horsley, talks about why you should attend this meeting in the video below:

Get hyped for the meeting and register today:

Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

Federal Funding provided by the National Institutes of Health:

Funding for this conference was made possible [in part] by 1R13AI186267-01 from the National Institute of Allergy and Infectious Diseases (NIAID). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

To access the NIH Safe Environment Policy, please click here.

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates